ExodusPoint Capital Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-85,863
| Closed | -$3.45M | – | 1482 |
|
|
2025
Q1 | $3.45M | Buy |
85,863
+76,539
| +821% | +$3.08M | 0.03% | 488 |
|
|
2024
Q4 | $439K | Sell |
9,324
-108,660
| -92% | -$5.12M | ﹤0.01% | 1080 |
|
|
2024
Q3 | $6.23M | Buy |
117,984
+25,051
| +27% | +$1.32M | 0.04% | 309 |
|
|
2024
Q2 | $5.04M | Buy |
92,933
+47,669
| +105% | +$2.58M | 0.03% | 359 |
|
|
2024
Q1 | $3.17M | Buy |
45,264
+42,130
| +1,344% | +$2.95M | 0.02% | 450 |
|
|
2023
Q4 | $262K | Sell |
3,134
-201,599
| -98% | -$16.9M | ﹤0.01% | 1145 |
|
|
2023
Q3 | $6.03M | Sell |
204,733
-8,159
| -4% | -$240K | 0.06% | 303 |
|
|
2023
Q2 | $6.95M | Sell |
212,892
-57,557
| -21% | -$1.88M | 0.06% | 301 |
|
|
2023
Q1 | $9.52M | Buy |
270,449
+109,116
| +68% | +$3.84M | 0.08% | 228 |
|
|
2022
Q4 | $7.39M | Buy |
+161,333
| New | +$7.39M | 0.11% | 234 |
|
|
2022
Q3 | – | Sell |
-98,740
| Closed | -$3.88M | – | 1909 |
|
|
2022
Q2 | $3.88M | Buy |
+98,740
| New | +$3.88M | 0.05% | 464 |
|
|
2022
Q1 | – | Sell |
-26,013
| Closed | -$1.19M | – | 2218 |
|
|
2021
Q4 | $1.19M | Sell |
26,013
-50,572
| -66% | -$2.31M | 0.01% | 947 |
|
|
2021
Q3 | $2.74M | Buy |
76,585
+45,070
| +143% | +$1.61M | 0.04% | 563 |
|
|
2021
Q2 | $624K | Sell |
31,515
-21,971
| -41% | -$435K | 0.01% | 1176 |
|
|
2021
Q1 | $1.24M | Buy |
+53,486
| New | +$1.24M | 0.02% | 759 |
|
|
2020
Q1 | – | Sell |
-19,384
| Closed | -$206K | – | 1134 |
|
|
2019
Q4 | $206K | Buy |
+19,384
| New | +$206K | ﹤0.01% | 1276 |
|